AKERO THERAPEUTICSCS INC
AKERO THERAPEUTICSCS INC
Share · US00973Y1082 · AKRO · A2PLNP (XNAS)
Overview Financial Indicators
54,65 USD
2,04 % 1,09 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 23:12

Current Prices from AKERO THERAPEUTICSCS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AKRO
USD
13.06.2025 23:12
54,65 USD
53,56 USD
+2,04 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -2,06 % 44,27 % 23,78 % 89,17 % 127,90 % 125,08 %

Company Profile for AKERO THERAPEUTICSCS INC Share

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Invested Funds

The following funds have invested in: AKERO THERAPEUTICSCS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
26,14
Percentage (%)
0,06 %

Company Data

Name AKERO THERAPEUTICSCS INC
Company Akero Therapeutics, Inc.
Symbol AKRO
Website https://www.akerotx.com
Primary Exchange XNAS NASDAQ
WKN A2PLNP
ISIN US00973Y1082
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Andrew Cheng M.D., Ph.D.
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 601 Gateway Boulevard, 94080 South San Francisco
IPO Date 2019-06-20

Ticker Symbols

Name Symbol
Frankfurt 0K4.F
NASDAQ AKRO

More Shares

Investors who AKERO THERAPEUTICSCS INC hold also have the following shares in their portfolio:
DEKA GM ANL 18/28
DEKA GM ANL 18/28 Bond
ELIA TRANSM. B. 20-30 MTN
ELIA TRANSM. B. 20-30 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025